血浆疗法市场:各类型，各用途，各终端用户，各地区-规模，占有率，展望，机会分析，2023年～2030年

全球血浆治疗市场预计在预测期内（2023-2030 年）复合年增长率为 14.2%。

血浆疗法是治疗冠状病毒和许多其他罕见和严重疾病的一种有前途的治疗方法。捐赠者提供的血液在处理设施中进行处理以获得血浆。同样，血浆从捐赠者中分离出来用于治疗冠状病毒感染的患者。捐赠者也可以是从感染中康復的患者。捐赠者的血浆由抗原或对抗冠状病毒的抗体组成。捐赠者的血液在处理中心进行处理并注入患者的血液中。

市场动态

监管机构有兴趣进行临床试验，为感染冠状病毒的患者开发新的治疗方法。例如，2020 年 4 月 18 日，印度药品监管总局 (DCGI) 宣布，印度医学研究委员会 (ICMR) 作为印度製定、协调和促进生物医学研究的最高机构，将接受一项提案，开展恢復期血浆的临床试验。ICMR已提交了对此临床试验感兴趣的研究机构名单。恢復期血浆疗法包括从 COVID-19 康復患者的血液中采集抗体，并将其注射到已注射患者的血液中。此临床试验旨在评估恢復期血浆在减少 COVID-19 患者併发症方面的有效性，并评估抗 SARS-CoV-2 血浆治疗冠状病毒感染患者的安全性。临床试验的增加预计将增加冠状病毒感染患者的治疗选择，并推动预测期内全球血浆治疗市场的成长。

该公司已获得监管部门批准建立新的製造工厂。例如，武田製药于 2021 年获得美国食品药物管理局 (FDA) 的批准，在乔治亚州卡温顿附近设立新的药品生产设施。该厂将生产 Flexbumin 25% [白蛋白（人），USP，25% 溶液]。此药适用于低渗透压血症、低蛋白血症、烧伤、成人呼吸窘迫症候群、肾臟病、体外循环手术和新生儿溶血病。新工厂预计将扩大公司的产品组合，并有利于预测期内全球血浆治疗市场的成长。

本调查的主要特征

• 本报告提供以2022年为基准年的预测期间（2023-2030 年）之全球血浆疗法市场的市场规模和復合年增长率（CAGR %）相关的详区隔析。
• 并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
• 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
• 并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球血浆疗法市场的主要参与者之企业简介。
• 藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• 全球血浆疗法市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以透过全球血浆疗法市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查目的与前提条件

• 调查目的
• 前提条件
• 简称

第2章 市场概况

• 报告概要
  • 市场定义和范围
• 摘要整理
• Coherent Opportunity Map(COM)

第3章 市场动态，法规，趋势分析

• 市场动态
  • 促进因素
  • 阻碍因素
  • 市场机会
• 影响分析
• 最近的产品销售
• 流行病学
• 合併和收购
• 产品核可
• 伙伴关係和合作
• 研究开发活动
• 法规情势
• 主要的发展
• PEST分析

第4章 由于血浆疗法的全球市场:COVID-19的影响分析

• 经济影响
• COVID-19流行病学
• 供需的影响

第5章 血浆疗法的全球市场:各类型，2018-2030年

• 纯PRP
• 富含白血球的PRP
• 纯富血小板纤维蛋白(PRF)
• 富含白血球纤维蛋白(L-PRF)

第6章 血浆疗法的全球市场:各用途，2018-2030年

• 感染疾病
• 牙科
• 神经损伤
• 心肌损伤
• 其他的应用

第7章 血浆疗法的全球市场:各终端用户，2018年～2030年

• 医院及诊所
• 研究机关
• 其他

第8章 血浆疗法的全球市场:各地区，2018-2030年

• 北美
• 美国
• 加拿大
• 南美
• 巴西
• 墨西哥
• 阿根廷
• 其他南美国家
• 欧洲
• 英国
• 德国
• 义大利
• 法国
• 西班牙
• 俄罗斯
• 其他欧洲
• 亚太地区
• 中国
• 印度
• 日本
• ASEAN
• 澳洲
• 韩国
• 其他亚太地区
• 中东
• GCC
• 以色列
• 其他中东
• 非洲
• 北非
• 中非
• 南非

第9章 竞争情形

• Octapharma AG
• Top Bio Group Co., Ltd
• Bio Products Laboratory Ltd
• Kedrion S.p.A
• Grifols, S.A
• CSL
• Biotest AG
• Takeda Pharmaceutical Company Limited
• DePuy Synthes(A subsidiary of Johnson & Johnson Services, Inc.)
• Regen Lab SA
• LFB S.A
• ImmunoTek Plasma

第10章 章节

• 调查手法
• 关于出版社

The global plasma therapy market is estimated to be valued at US$ 334.5 Mn in 2023 and is expected to exhibit a CAGR of 14.2% during the forecast period (2023-2030).

Plasma therapy is a promising treatment against coronaviruses, and many rare other and serious disorders. The blood that is donated by the donor is processed in a processing facility to obtain plasma. Similarly, for the treatment of coronavirus-infected patients, the plasma is isolated from the donor. The donor is also the patient who has recovered from the infection. The donor plasma consists of antibodies that were generated in order to fight the antigens, i.e., the coronavirus. The blood from the donor is processed in processing centers and then injected into the blood of the patients.

Market Dynamics

Regulatory authorities are interested in conducting clinical trials for the development of new treatment options for coronavirus infected patients. For instance, on April 18, 2020, The Drug Controller General of India (DCGI) accepted the proposal of the Indian Council of Medical Research (ICMR), the apex body in India for the formulation, coordination, and promotion of biomedical research, for conducting clinical trials of convalescent plasma in COVID-19 patients. The ICMR has submitted a list of institutes that are interested in the trial. In convalescent plasma therapy, the antibodies are recovered from the blood of patients who have recovered from COVID-19 and injected into the blood of injected patients. The clinical trial aims to assess the efficacy of convalescent plasma to limit complications in COVID-19 patients and to evaluate the safety of treatment with anti SARS-CoV-2 plasma in coronavirus-infected patients. The rising number of clinical trials is expected to increase treatment options for coronavirus infected patients and spur global plasma therapy market growth during the forecast period.

Companies are receiving approvals from regulatory authorities for the setup of a new manufacturing facility. For instance, in 2021, Takeda Pharmaceutical Company Limited received approval from the U.S Food and Drug Administration (U.S FDA) for its new pharmaceutical manufacturing facility near Covington, Georgia. The facility will produce FLEXBUMIN 25% [Albumin (Human), USP, 25% Solution]. The medicine is indicated for hypovolemia, hypoalbuminemia, (burns, Adult Respiratory Distress Syndrome, and nephrosis, cardiopulmonary bypass surgery, and hemolytic disease of newborns. The new facility will expand the product portfolio of the company which is expected to favor the global plasma therapy market growth during the forecast period.international distributors.

Key features of the study:

• This report provides an in-depth analysis of the global plasma therapy market and provides market size (US$ Mn) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global plasma therapy market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Octapharma AG, Top Bio Group Co., Ltd, Bio Products Laboratory Ltd, Kedrion S.p.A, Grifols, S.A, CSL, Biotest AG, Takeda Pharmaceutical Company Limited, DePuy Synthes (A subsidiary of Johnson & Johnson Services, Inc.), Regen Lab SA, LFB S.A, ImmunoTek Plasma.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global plasma therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global plasma therapy market.

Detailed Segmentation:

• Global Plasma Therapy Market, By Type:
  • Pure PRP
  • Leucocyte-rich PRP
  • Pure Platelet-rich Fibrin (PRF)
  • Leukocyte-rich Fibrin (L-PRF)
• Global Plasma Therapy Market, By Appication:
  • Infectious Diseases
  • Dental
  • Nerve Injury
  • Cardiac Muscle Injury
  • Other Applications
• Global Plasma Therapy Market, By End user:
  • Hospitals and Clinics
  • Research Institutes
  • Others
• Global Plasma Therapy Market, By Region:
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Octapharma AG
  • Top Bio Group Co., Ltd
  • Bio Products Laboratory Ltd
  • Kedrion S.p.A
  • Grifols, S.A
  • Cochin Shipyard Limited
  • Biotest AG
  • Takeda Pharmaceutical Company Limited
  • DePuy Synthes (A subsidiary of Johnson & Johnson Services, Inc.)
  • Regen Lab SA
  • LFB S.A
  • ImmunoTek Plasma

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Application
  • Market Snapshot, By End user
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Product Launches
• Epidemiology
• Mergers and Acquisition
• Product Approvals
• Partnerships and Collaborations
• Research and Development Activities
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Plasma Therapy Market- COVID-19 Impact Analysis

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Plasma Therapy Market, By Type, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Pure PRP
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Leucocyte-rich PRP
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Pure Platelet-rich Fibrin (PRF)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Leukocyte-rich Fibrin (L-PRF)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

6. Global Plasma Therapy Market, By Application, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Dental
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Nerve Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Cardiac Muscle Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Other Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Global Plasma Therapy Market, By End user, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

8. Global Plasma Therapy Market, By Region, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2018-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Octapharma AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Top Bio Group Co., Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bio Products Laboratory Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Kedrion S.p.A
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Grifols, S.A
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• CSL
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Biotest AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Takeda Pharmaceutical Company Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• DePuy Synthes (A subsidiary of Johnson & Johnson Services, Inc.)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Regen Lab SA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• LFB S.A
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ImmunoTek Plasma
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us